U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 1 - 10 of 17 results

structurally diverse
Status:
US Approved Rx (2019)
Source:
BLA125682
(2019)
Source URL:
First approved in 2019
Source:
BLA125682
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2019)
Source:
BLA125682
(2019)
Source URL:
First approved in 2019
Source:
BLA125682
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2019)
Source:
BLA125682
(2019)
Source URL:
First approved in 2019
Source:
BLA125682
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2019)
Source:
BLA125682
(2019)
Source URL:
First approved in 2019
Source:
BLA125682
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (1999)
Source:
BLA103915
(1999)
Source URL:
First approved in 1953
Source:
Yf-Vax by Sanofi Pasteur Inc.
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT00981630: Phase 2 Interventional Completed Japanese Encephalitis
(2004)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Other

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Other

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Other

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Other

Class:
STRUCTURALLY DIVERSE

Showing 1 - 10 of 17 results